Allen Ho, MD

Allen Ho, MD

Otolaryngology (ENT) in Los Angeles, CA

Hide Show

Speaks English and Chinese (Mandarin)


 (310) 423-1220

Contact


Hide Show

Office Hours

Monday:
8:00 am - 5:00 pm
Tuesday:
8:00 am - 5:00 pm
Wednesday:
8:00 am - 5:00 pm
Thursday:
8:00 am - 5:00 pm
Friday:
8:00 am - 5:00 pm
Saturday:
Closed
Sunday:
Closed
Hide Show

About Dr. Ho


Allen S. Ho MD is Associate Professor of Surgery, Director of the Head and Neck Cancer Program, and Co-Director of the Thyroid Cancer Program at Cedars-Sinai Medical Center. As a fellowship-trained head and neck surgeon. His practice focuses on the treatment of head and neck tumors, including HPV(+) throat cancers and thyroid malignancies. He leads the multidisciplinary Cedars-Sinai Head and Neck Tumor Board, which provides consensus management options for complex, advanced cases. Dr. Ho’s research interests are highly integrated into his clinical practice. His current efforts lie in cancer proteomics, HPV(+) oropharyngeal cancer pathogenesis, and thyroid cancer molecular assays. Dr. Ho has published as lead author in journals that include Nature Genetics, JCO, JAMA Oncology, and Thyroid, and is Editor of the textbook Multidisciplinary Care of the Head and Neck Cancer Patient (Springer 2018). Dr. Ho serves on national committees within the AHNS and ATA, and leads a national trial on thyroid cancer active surveillance (ClinicalTrials.gov ID: NCT02609685). He maintains expertise in transoral robotic surgery (TORS), minimally invasive thyroidectomy approaches, and nerve preservation techniques. Dr. Ho’s overarching aim is to partner with patients to optimize treatment and provide compassionate, exceptional care.

Hide Show

Services Offered



Head and neck cancer
Hyperparathyroidism
Thyroid cancer
Head and neck oncology
Thyroid surgery
Parathyroid surgery
Robotic head and neck surgery
Head and neck surgery

Qualifications and Experience



Hide Show

Education & Training

Memorial Sloan-Kettering Cancer Center
Fellowship, Head and Neck Surgery, 2011 - 2014

Stanford University
Residency, Otolaryngology, 2006 - 2011

Stanford University
Internship, General Surgery, 2006 - 2007

UCLA
Class of 2006

National Cancer Institute
Post-Doctoral Fellowship, 2003 - 2004

Harvard University
BA, Neurobiology, 1996 - 2000

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Certifications

American Board of Otolaryngology - Head and Neck Surgery
Otolaryngology

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Medical Licenses

NY State Medical License
2011 - 2014

CA State Medical License
2007 - 2019

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Work Experience

Director, Head and Neck Cancer Program
Cedars-Sinai Medical Center
Los Angeles, CA
Present

Co-Director, Thyroid Cancer Program
Cedars-Sinai Medical Center
Los Angeles, CA
Present

Associate Professor
Cedars-Sinai Medical Center
Los Angeles, CA
Present

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Hospital Affiliations

Cedars-Sinai Medical Center
Current Affiliation
Los Angeles, CA

Memorial Sloan-Kettering Cancer Center
Former Affiliation
New York, NY

Stanford University
Former Affiliation
Palo Alto, CA

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Awards

Precision Health Initiative Grant
2018

Super Doctors
2018

Best Doctors in America
2017

Top Doctors
2017

Donna and Jesse Garber Award for Cancer Research
2017

National Health Network Foundation Grant
2016

Adenoid Cystic Carcinoma Foundation Grant
2014

AHNS Young Investigator Award
2013

NIH Ruth Kirschstein National Research Service Award
2013

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Professional Memberships

American Academy of Otolaryngology - Head and Neck Surgery - AAO - NHS
Member

American Thyroid Association - ATA
Member

American Head and Neck Society - AHNS
Member

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Publications



PubMed

The mutational landscape of adenoid cystic carcinoma.
Nat Genet
Ho AS Kannan K Roy DM Morris LG Ganly I Katabi N Ramaswami D Walsh LA Eng S Huse JT Zhang J Dolgalev I Huberman K Heguy A Viale A Drobnjak M Leversha MA Rice CE Singh B Iyer NG Leemans CR Bloemena E Ferris RL Seethala RR Gross BE Liang Y Sinha R Peng L Raphael BJ Turcan S Gong Y Schultz N Kim S Chiosea S Shah JP Sander C Lee W Chan TA
5/19/2013

Malignancy rate in thyroid nodules classified as Bethesda Category III (AUS/FLUS).
Thyroid
Ho, A. S.,Sarti, E. E.,Jain, K. S.,Wang, H.,Nixon, I. J.,Shaha, A. R.,Shah, J. P.,Kraus, D.,Ghossein, R.,Fish, S.,Wong, R. J.,Lin, O.,Morris, L. G.
12/18/2013

Decision making in the management of recurrent head and neck cancer.
Head Neck
Ho, A. S.,Kraus, D. H.,Ganly, I.,Lee, N. Y.,Shah, J. P.,Morris, L. G.
3/8/2013
43 citations

See All

Journal Article

Association of quantitative metastatic lymph node burden with survival in hypopharyngeal and laryngeal cancer
JAMA Oncology
Ho AS, Kim S, Tighiouart M, Gudino C, Mita A, Scher KS, Laury A, Prasad R, Shiao SL, Ali N, Patio C, Mallen-St Clair J, Van Eyk JE, Zumsteg ZS
11/30/2017

Metastatic lymph node burden and survival in oral cavity cancer
Journal of Clinical Oncology
Ho AS, Kim S, Tighiouart M, Gudino C, Mita A, Scher KS, Laury A, Prasad R, Shiao SL, Van Eyk JE, Zumsteg ZS
11/1/2017

Impact of Afirma gene expression classifier on cytopathology diagnosis and rate of thyroidectomy
Cancer
Sacks WL, Bose S, Zumsteg ZS, Wong R, Shiao SL, Braunstein GD, Ho AS
10/1/2016

Lecture

Low-risk thyroid cancers
10/1/2017
American Thyroid Association Annual Meeting, Victoria BC, Canada

The calibrated thyroid surgeon: how ATA has modernized thyroid cancer management
9/1/2017
Thyroid Cancer Grand Rounds, Cedars-Sinai Medical Center, Los Angeles, CA

Anaplastic thyroid carcinoma: managment principles for an unprincipled disease
10/1/2016
Advances in the Management of Thyroid Cancer Symposium, Los Angeles, CA

Abstract

Survival impact of treatment interval delays in head and neck cancer
ASTRO/ASCO/AHNS Multidisciplinary Head and Neck Cancer Symposium
Ho AS, Kim S, Tighiouart M, Mita A, Scher K, Mallen-St. Clair J, Zumsteg ZS
2/1/2018
Scottsdale, AZ

Proteomic stratification of HPV(+) oropharyngeal squamous cell carcinoma identifies targets in insulin receptor signaling within nonresponders
AACR-AHNS Head and Neck Cancer Conference
Robinson A, Laury A, Parker SJ, Shiao SL, Knudsen B, Zumsteg ZS, Van Eyk JE, Ho AS
1/1/2017
San Diego, CA

Management trends in active surveillance of papillary thyroid microcarcinoma
American Thyroid Association (ATA) Annual Meeting
Sacks WL, Melany ML, Chen IE, Braunstein GD, Ho AS
9/1/2016
Denver, CO

Book Chapter

Multidisciplinary Care of the Head and Neck Cancer Patient
Ho AS, Maghami E
3/1/2018

Textbook of General Surgical Oncology
Ho AS, Patel SG
1/1/2017

Cummings Otolaryngology-Head and Neck Surgery
Ho AS, Zanation AM, Ganly I.
1/1/2015

█████ ████ ███
▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄▄▄ ▄▄ ▄▄▄▄▄
▄▄▄▄▄▄▄ ▄▄▄▄▄▄ ▄▄▄
Hide Show

Press Mentions



Number of Metastatic Lymph Nodes and Survival in Hypopharyngeal/Laryngeal Cancer
ascopost.com · December 14, 2017
...nter for Advancing Translational Sciences and the Donna and Jesse Garber Award for Cancer Research. Allen S. Ho, MD, of the Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, is the corresponding a...

Number of Metastatic Nodes a Predictor for Survival in Oral Cancer
OncLive · October 23, 2017
Allen S. Ho, MD The presence of metastatic lymph nodes was directly correlated with poorer survival in patients...

Baby Boomers Experiencing High Rates of Throat Cancer
Newsmax Media · April 04, 2017
...n it comes to throat cancer, the key demographic experiencing an increase is the baby boomers,” Dr. Allen Ho tells Newsmax Health. The rate of throat cancer increased 200 percent during the 10-year period bet...